FDA Attorney

FDA Warns Companies Marketing Supplements Containing DMAA

On April 27, 2012, the U.S. Food and Drug Administration (“FDA”) issued warning letters to several dietary supplement manufacturers in…

FDA Approves Vivus Inc.’s Stendra to Treat Erectile Dysfunction

On April 27, 2012, the U.S. Food and Drug Administration (“FDA”) approved the drug Stendra (avanafil), a drug used to…

FDA Issues Statement on USDA BSE (“mad-cow”) Case

On April 26, 2012, the U.S. Food and Drug Administration (“FDA”) issued a statement concerning the recent announcement confirming a…

FDA Publishes Global Engagement Report, Highlighting Efforts Abroad

On April 23, 2012, the U.S. Food and Drug Administration (“FDA”) released its “Global Engagement Report,” a document detailing the…

FDA Enters into Consent Decree with Seafood Processor over Alleged Manufacturing Deficiencies

On April 11, 2012, the U.S. Food and Drug Administration (“FDA”) announced that, with the aid of the Department of…

FDA Warns Consumers of Dangers Associated with Crackers Lacking Proper Allergy Warnings

On April 5, 2012, the U.S. Food and Drug Administration (“FDA”) issued a press release warning consumers not to eat…

FDA Enters Into Consent Decree of Permanent Injunction with Cheese Producer Due to Listeria Contamination

On April 9, 2012, the U.S. Food and Drug Administration (“FDA”) announced it has entered into a consent decree with a…

FDA Denies Petition to Ban BPA

On March 30, 2012, the U.S. Food and Drug Administration (“FDA”) denied a request to ban the chemical bisphenol-A, commonly…

FDA Proposes Reclassification of Tuberculosis Tests

On March 16, 2012, the U.S. Food and Drug Administration (“FDA”) announced its issuance of a proposed rule intended to…

FDA Approves Boniva Generics

On March 19, 2012, the U.S. Food and Drug Administration (“FDA”) announced the approval of generic versions of the drug…